Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine quadratus lumborum block for analgesia after gynecological single-incision laparoscopy
ChiCTR2500104156Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Total oxycodone consumption within 72 hours after surgery and Number of PCIA presses and time to first press. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500104156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104156.